BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34042518)

  • 41. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
    Pirim D
    Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
    Li D; Yin Y; He M; Wang J
    Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Sun Y; Zhang Z
    Genet Test Mol Biomarkers; 2020 May; 24(5):296-308. PubMed ID: 32384023
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of potential biomarkers for colorectal cancer by clinical database analysis and Kaplan-Meier curves analysis.
    Li C; Gao Y; Lu C; Guo M
    Medicine (Baltimore); 2023 Feb; 102(6):e32877. PubMed ID: 36820595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
    Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
    Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
    Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
    Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
    Li J; Wang Y; Wang X; Yang Q
    World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.
    Qiu X; Feng JR; Wang F; Chen PF; Chen XX; Zhou R; Chang Y; Liu J; Zhao Q
    Mol Med Rep; 2018 Feb; 17(2):3028-3034. PubMed ID: 29257257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RRP9 and DDX21 as new biomarkers of colorectal cancer.
    Chi X; Yang N; Liu Y
    Medicine (Baltimore); 2023 Oct; 102(43):e34384. PubMed ID: 37904456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
    Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
    Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and Verification of Core Genes in Colorectal Cancer.
    Xu H; Ma Y; Zhang J; Gu J; Jing X; Lu S; Fu S; Huo J
    Biomed Res Int; 2020; 2020():8082697. PubMed ID: 32462020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics.
    Dong C; Tian X; He F; Zhang J; Cui X; He Q; Si P; Shen Y
    J Ovarian Res; 2021 Jul; 14(1):92. PubMed ID: 34253236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
    Shaath H; Vishnubalaji R; Elango R; Velayutham D; Jithesh PV; Alajez NM
    Cell Commun Signal; 2023 Sep; 21(1):265. PubMed ID: 37770979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.